1. Home
  2. MDAIW vs NTES Comparison

MDAIW vs NTES Comparison

Compare MDAIW & NTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAIW
  • NTES
  • Stock Information
  • Founded
  • MDAIW N/A
  • NTES 1997
  • Country
  • MDAIW United States
  • NTES China
  • Employees
  • MDAIW 78
  • NTES N/A
  • Industry
  • MDAIW Medical/Dental Instruments
  • NTES Computer Software: Prepackaged Software
  • Sector
  • MDAIW Health Care
  • NTES Technology
  • Exchange
  • MDAIW Nasdaq
  • NTES Nasdaq
  • Market Cap
  • MDAIW N/A
  • NTES N/A
  • IPO Year
  • MDAIW 2021
  • NTES 2000
  • Fundamental
  • Price
  • MDAIW $0.11
  • NTES $88.64
  • Analyst Decision
  • MDAIW
  • NTES Strong Buy
  • Analyst Count
  • MDAIW 0
  • NTES 7
  • Target Price
  • MDAIW N/A
  • NTES $107.29
  • AVG Volume (30 Days)
  • MDAIW N/A
  • NTES 1.6M
  • Earning Date
  • MDAIW N/A
  • NTES 11-14-2024
  • Dividend Yield
  • MDAIW N/A
  • NTES 1.96%
  • EPS Growth
  • MDAIW N/A
  • NTES 3.25
  • EPS
  • MDAIW N/A
  • NTES 1.21
  • Revenue
  • MDAIW N/A
  • NTES $15,067,016,873.00
  • Revenue This Year
  • MDAIW N/A
  • NTES $5.31
  • Revenue Next Year
  • MDAIW N/A
  • NTES $8.34
  • P/E Ratio
  • MDAIW N/A
  • NTES $14.44
  • Revenue Growth
  • MDAIW N/A
  • NTES 3.94
  • 52 Week Low
  • MDAIW N/A
  • NTES $75.85
  • 52 Week High
  • MDAIW N/A
  • NTES $115.43
  • Technical
  • Relative Strength Index (RSI)
  • MDAIW N/A
  • NTES 60.43
  • Support Level
  • MDAIW N/A
  • NTES $85.46
  • Resistance Level
  • MDAIW N/A
  • NTES $89.25
  • Average True Range (ATR)
  • MDAIW 0.00
  • NTES 1.86
  • MACD
  • MDAIW 0.00
  • NTES 1.30
  • Stochastic Oscillator
  • MDAIW 0.00
  • NTES 95.44

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: